Skip to main content

FDA panel backs plan for annual COVID-19 booster, as new omicron subvariant continues to dominate in new cases

An FDA panel endorsed the agency's plan for a once-a-year COVID-19 booster. And CDC data shows that XBB.1.5 continues to lead other variants in the U.S.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.